The settlement, worth around $260 million, involves McKesson, Cardinal Health, AmerisourceBergen and Teva. McKesson, Cardinal Health and AmerisourceBergen will pay $215 million to the two Ohio counties that filed suit. Teva will pay at least $20 million in cash and donate $25 million worth of addiction treatment drugs. However, the details of the settlement have yet to be released.
The lawsuits filed by Ohio’s Cuyahoga and Summit counties were first to go to trial out of more than 2,300 opioid lawsuits brought in federal court and consolidated before U.S. District Judge Dan Polster in Cleveland, according to The Wall Street Journal.
The lawsuits claim pharmaceutical companies pushed opioid pain medications for widespread use without adequately warning of the risks of addiction, and distributors enabled the shipping of high volumes of pills into communities.
A broader settlement to resolve the thousands of other cases against the companies may be announced later in the day by state attorneys general, people familiar with the discussions told The New York Times.
A smaller distributor, Henry Schein Medical, also reached a settlement, agreeing to pay $1 million to a grant-making foundation that focuses on alternative pain treatments and $250,000 for the plaintiffs’ legal fees.
More articles on opioids:
Drugmakers, distributors nearing $50B opioid settlement
Top distributors may settle opioid litigation for $18B
HHS creates clinician resource for tapering patients’ opioid use
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.